Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SUSD6 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
mRNA | FBXO5 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.03 |
mRNA | GLT1D1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
mRNA | UNK | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
mRNA | GOLGA8N | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | AC004381.6 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
mRNA | CGN | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
mRNA | PQBP1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
mRNA | FDXACB1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
mRNA | GATS | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |